HEADER PROTEIN BINDING/INHIBITOR 11-AUG-11 3TDZ TITLE N-TERMINAL ACETYLATION ACTS AS AN AVIDITY ENHANCER WITHIN AN TITLE 2 INTERCONNECTED MULTIPROTEIN COMPLEX: STRUCTURE OF A HUMAN CUL1WHB- TITLE 3 DCN1P-STAPLED ACETYLATED UBC12N COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: DCN1-LIKE PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 62-259; COMPND 5 SYNONYM: DCUN1 DOMAIN-CONTAINING PROTEIN 1, DEFECTIVE IN CULLIN COMPND 6 NEDDYLATION PROTEIN 1-LIKE PROTEIN 1, SQUAMOUS CELL CARCINOMA-RELATED COMPND 7 ONCOGENE; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CULLIN-1; COMPND 11 CHAIN: C, D; COMPND 12 FRAGMENT: UNP RESIDUES 702-776; COMPND 13 SYNONYM: CUL-1; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: STAPLED PEPTIDE; COMPND 17 CHAIN: E, F; COMPND 18 FRAGMENT: UNP RESIDUES 2-12; COMPND 19 SYNONYM: NEDD8-CONJUGATING ENZYME UBC12, NEDD8 CARRIER PROTEIN, NEDD8 COMPND 20 PROTEIN LIGASE, UBIQUITIN-CONJUGATING ENZYME E2 M; COMPND 21 EC: 6.3.2.-; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DCUN1D1, DCUN1L1, RP42, SCCRO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CUL1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606 KEYWDS E2:E3, PROTEIN BINDING-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.C.SCOTT,J.K.MONDA,E.J.BENNETT,J.W.HARPER,B.A.SCHULMAN REVDAT 7 06-NOV-24 3TDZ 1 REMARK REVDAT 6 06-DEC-23 3TDZ 1 REMARK REVDAT 5 13-SEP-23 3TDZ 1 SEQADV LINK REVDAT 4 08-NOV-17 3TDZ 1 REMARK REVDAT 3 17-APR-13 3TDZ 1 REMARK REVDAT 2 23-NOV-11 3TDZ 1 JRNL REVDAT 1 12-OCT-11 3TDZ 0 JRNL AUTH D.C.SCOTT,J.K.MONDA,E.J.BENNETT,J.W.HARPER,B.A.SCHULMAN JRNL TITL N-TERMINAL ACETYLATION ACTS AS AN AVIDITY ENHANCER WITHIN AN JRNL TITL 2 INTERCONNECTED MULTIPROTEIN COMPLEX. JRNL REF SCIENCE V. 334 674 2011 JRNL REFN ISSN 0036-8075 JRNL PMID 21940857 JRNL DOI 10.1126/SCIENCE.1209307 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 53080 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2840 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2963 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 74.03 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 147 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4593 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 485 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : 0.86000 REMARK 3 B33 (A**2) : -0.87000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.159 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.143 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.099 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.870 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4733 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6331 ; 0.982 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 550 ; 4.588 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 231 ;35.160 ;24.978 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 922 ;12.118 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;16.441 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 682 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3472 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2810 ; 0.417 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4511 ; 0.809 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1923 ; 1.255 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1819 ; 2.162 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 61 A 151 REMARK 3 RESIDUE RANGE : A 152 A 220 REMARK 3 RESIDUE RANGE : A 221 A 250 REMARK 3 ORIGIN FOR THE GROUP (A): -2.4510 49.5970 1.4690 REMARK 3 T TENSOR REMARK 3 T11: 0.0640 T22: 0.2026 REMARK 3 T33: 0.0718 T12: -0.0156 REMARK 3 T13: 0.0080 T23: 0.0406 REMARK 3 L TENSOR REMARK 3 L11: 3.2920 L22: 0.3953 REMARK 3 L33: 0.6075 L12: 0.3959 REMARK 3 L13: -1.0991 L23: -0.0932 REMARK 3 S TENSOR REMARK 3 S11: 0.0799 S12: 0.2623 S13: 0.1822 REMARK 3 S21: 0.0348 S22: 0.0377 S23: 0.0764 REMARK 3 S31: -0.0945 S32: 0.0208 S33: -0.1176 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 702 C 722 REMARK 3 RESIDUE RANGE : C 723 C 740 REMARK 3 RESIDUE RANGE : C 741 C 776 REMARK 3 ORIGIN FOR THE GROUP (A): -28.0620 37.1580 -7.7290 REMARK 3 T TENSOR REMARK 3 T11: 0.0185 T22: 0.3285 REMARK 3 T33: 0.0471 T12: 0.0053 REMARK 3 T13: -0.0056 T23: 0.0192 REMARK 3 L TENSOR REMARK 3 L11: 4.0541 L22: 5.8977 REMARK 3 L33: 3.1003 L12: 3.1061 REMARK 3 L13: -0.4984 L23: -1.3004 REMARK 3 S TENSOR REMARK 3 S11: -0.1752 S12: 0.7432 S13: -0.0328 REMARK 3 S21: -0.1482 S22: 0.4338 S23: 0.0489 REMARK 3 S31: 0.1454 S32: 0.1729 S33: -0.2587 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 61 B 151 REMARK 3 RESIDUE RANGE : B 152 B 220 REMARK 3 RESIDUE RANGE : B 221 B 250 REMARK 3 ORIGIN FOR THE GROUP (A): -21.5810 91.9780 -18.3230 REMARK 3 T TENSOR REMARK 3 T11: 0.2380 T22: 0.1030 REMARK 3 T33: 0.0376 T12: 0.0032 REMARK 3 T13: 0.0637 T23: -0.0076 REMARK 3 L TENSOR REMARK 3 L11: 0.2608 L22: 4.1819 REMARK 3 L33: 1.5003 L12: -0.1929 REMARK 3 L13: 0.0888 L23: 1.2920 REMARK 3 S TENSOR REMARK 3 S11: -0.0116 S12: 0.0541 S13: -0.0107 REMARK 3 S21: -0.1062 S22: 0.1447 S23: -0.2040 REMARK 3 S31: -0.4308 S32: 0.1839 S33: -0.1331 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 701 D 722 REMARK 3 RESIDUE RANGE : D 723 D 740 REMARK 3 RESIDUE RANGE : D 741 D 775 REMARK 3 ORIGIN FOR THE GROUP (A): -33.9270 66.3760 -8.7270 REMARK 3 T TENSOR REMARK 3 T11: 0.1072 T22: 0.1346 REMARK 3 T33: 0.0389 T12: 0.0929 REMARK 3 T13: 0.0218 T23: -0.0069 REMARK 3 L TENSOR REMARK 3 L11: 3.6105 L22: 4.7095 REMARK 3 L33: 3.7183 L12: 2.5211 REMARK 3 L13: 0.4527 L23: -0.6867 REMARK 3 S TENSOR REMARK 3 S11: 0.0941 S12: 0.1243 S13: -0.0173 REMARK 3 S21: 0.3561 S22: 0.0897 S23: 0.0588 REMARK 3 S31: -0.2396 S32: -0.2203 S33: -0.1838 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 1 E 11 REMARK 3 ORIGIN FOR THE GROUP (A): 7.7460 41.1920 11.1270 REMARK 3 T TENSOR REMARK 3 T11: 0.0776 T22: 0.2660 REMARK 3 T33: 0.1243 T12: -0.0335 REMARK 3 T13: 0.0067 T23: -0.0712 REMARK 3 L TENSOR REMARK 3 L11: 9.1336 L22: 13.1383 REMARK 3 L33: 16.5587 L12: -6.0811 REMARK 3 L13: 5.8290 L23: -9.3895 REMARK 3 S TENSOR REMARK 3 S11: 0.1360 S12: 0.3182 S13: -0.1443 REMARK 3 S21: -0.5385 S22: 0.1764 S23: 0.1074 REMARK 3 S31: 0.4588 S32: 0.3578 S33: -0.3124 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : F 1 F 11 REMARK 3 ORIGIN FOR THE GROUP (A): -29.9200 103.1940 -27.9850 REMARK 3 T TENSOR REMARK 3 T11: 0.5387 T22: 0.1293 REMARK 3 T33: 0.1712 T12: 0.0112 REMARK 3 T13: 0.1079 T23: -0.0070 REMARK 3 L TENSOR REMARK 3 L11: 9.2569 L22: 10.2455 REMARK 3 L33: 12.9210 L12: -3.5372 REMARK 3 L13: 5.8210 L23: -8.4112 REMARK 3 S TENSOR REMARK 3 S11: 0.1524 S12: -0.5577 S13: 0.0297 REMARK 3 S21: 0.2935 S22: 0.2551 S23: 0.6451 REMARK 3 S31: -0.3627 S32: -0.5453 S33: -0.4075 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3TDZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000067364. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : UNBUFFERED REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL - LIQUID NITROGEN REMARK 200 COOLED REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53080 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.474 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : 0.07800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.43900 REMARK 200 R SYM FOR SHELL (I) : 0.43900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 3TDU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21% PEG3350, 0.2M KCL, PH UNBUFFERED, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.75300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.75300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 65.89500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 95.10500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 65.89500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 95.10500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.75300 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 65.89500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 95.10500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 33.75300 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 65.89500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 95.10500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE [(5S)-5-[[(2S,3S)-2-[[(2S)-2-ACETAMIDO-4-METHYLSELANYL-BUTANOYL] REMARK 400 AMINO]-3-METHYL-PENTANOYL]AMINO]-6-[[(2S)-1-[[(3S,6S,9S,12S,21S)-3- REMARK 400 (4-AZANIUMYLBUTYL)-21-[[(2S)-1-[[(2S)-6-AZANIUMYL-1-OXIDANYL-1- REMARK 400 OXIDANYLIDENE-HEXAN-2-YL]AMINO]-5-AZANYL-1,5-BIS(OXIDANYLIDENE) REMARK 400 PENTAN-2-YL]CARBAMOYL]-9-(HYDROXYMETHYL)-12,21-DIMETHYL-6-(2- REMARK 400 METHYLPROPYL)-2,5,8,11-TETRAKIS(OXIDANYLIDENE)-1,4,7,10- REMARK 400 TETRAZACYCLOHENICOS-12-YL]AMINO]-4-METHYL-1-OXIDANYLIDENE-PENTAN-2- REMARK 400 YL]AMINO]-6-OXIDANYLIDENE-HEXYL]AZANIUM IS OLIGOPEPTIDE, A MEMBER REMARK 400 OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: [(5S)-5-[[(2S,3S)-2-[[(2S)-2-ACETAMIDO-4-METHYLSELANYL- REMARK 400 BUTANOYL]AMINO]-3-METHYL-PENTANOYL]AMINO]-6-[[(2S)-1-[[(3S, REMARK 400 6S,9S,12S,21S)-3-(4-AZANIUMYLBUTYL)-21-[[(2S)-1-[[(2S)-6- REMARK 400 AZANIUMYL-1-OXIDANYL-1-OXIDANYLIDENE-HEXAN-2-YL]AMINO]-5- REMARK 400 AZANYL-1,5-BIS(OXIDANYLIDENE)PENTAN-2-YL]CARBAMOYL]-9- REMARK 400 (HYDROXYMETHYL)-12,21-DIMETHYL-6-(2-METHYLPROPYL)-2,5,8,11- REMARK 400 TETRAKIS(OXIDANYLIDENE)-1,4,7,10-TETRAZACYCLOHENICOS-12-YL] REMARK 400 AMINO]-4-METHYL-1-OXIDANYLIDENE-PENTAN-2-YL]AMINO]-6- REMARK 400 OXIDANYLIDENE-HEXYL]AZANIUM REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 60 REMARK 465 ALA A 252 REMARK 465 GLY A 253 REMARK 465 THR A 254 REMARK 465 LYS A 255 REMARK 465 SER A 256 REMARK 465 THR A 257 REMARK 465 THR A 258 REMARK 465 VAL A 259 REMARK 465 GLY C 700 REMARK 465 GLY B 60 REMARK 465 GLY B 253 REMARK 465 THR B 254 REMARK 465 LYS B 255 REMARK 465 SER B 256 REMARK 465 THR B 257 REMARK 465 THR B 258 REMARK 465 VAL B 259 REMARK 465 GLY D 700 REMARK 465 ALA D 776 REMARK 465 LYS E 12 REMARK 465 LYS F 12 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 67 CG CD OE1 NE2 REMARK 470 GLN B 67 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS E 8 O HOH A 435 3555 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS F 8 O - C - N ANGL. DEV. = -9.8 DEGREES REMARK 500 MK8 F 9 C - N - CA ANGL. DEV. = 16.1 DEGREES REMARK 500 GLN F 10 C - N - CA ANGL. DEV. = 17.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 204 -62.21 -126.21 REMARK 500 LYS C 723 -50.66 67.84 REMARK 500 LEU C 775 -102.19 -123.33 REMARK 500 ALA B 235 49.31 -88.90 REMARK 500 LYS D 723 -49.49 69.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3TDI RELATED DB: PDB REMARK 900 RELATED ID: 3TDU RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SIDE CHAINS OF MK8 RESIDUE OF CHAIN E/F AND NUMBERS 5 AND 9 ARE REMARK 999 LINKED BY A DOUBLE BOND AT THE CE ATOMS DBREF 3TDZ A 62 259 UNP Q96GG9 DCNL1_HUMAN 62 259 DBREF 3TDZ C 702 776 UNP Q13616 CUL1_HUMAN 702 776 DBREF 3TDZ B 62 259 UNP Q96GG9 DCNL1_HUMAN 62 259 DBREF 3TDZ D 702 776 UNP Q13616 CUL1_HUMAN 702 776 DBREF 3TDZ E 2 12 UNP P61081 UBC12_HUMAN 2 12 DBREF 3TDZ F 2 12 UNP P61081 UBC12_HUMAN 2 12 SEQADV 3TDZ GLY A 60 UNP Q96GG9 EXPRESSION TAG SEQADV 3TDZ SER A 61 UNP Q96GG9 EXPRESSION TAG SEQADV 3TDZ GLY C 700 UNP Q13616 EXPRESSION TAG SEQADV 3TDZ SER C 701 UNP Q13616 EXPRESSION TAG SEQADV 3TDZ GLY B 60 UNP Q96GG9 EXPRESSION TAG SEQADV 3TDZ SER B 61 UNP Q96GG9 EXPRESSION TAG SEQADV 3TDZ GLY D 700 UNP Q13616 EXPRESSION TAG SEQADV 3TDZ SER D 701 UNP Q13616 EXPRESSION TAG SEQADV 3TDZ ACE E 0 UNP P61081 ACETYLATION SEQADV 3TDZ MSE E 1 UNP P61081 INITIATING METHIONINE SEQADV 3TDZ MK8 E 5 UNP P61081 PHE 5 ENGINEERED MUTATION SEQADV 3TDZ MK8 E 9 UNP P61081 GLN 9 ENGINEERED MUTATION SEQADV 3TDZ ACE F 0 UNP P61081 ACETYLATION SEQADV 3TDZ MSE F 1 UNP P61081 INITIATING METHIONINE SEQADV 3TDZ MK8 F 5 UNP P61081 PHE 5 ENGINEERED MUTATION SEQADV 3TDZ MK8 F 9 UNP P61081 GLN 9 ENGINEERED MUTATION SEQRES 1 A 200 GLY SER ARG LYS LYS LEU GLU GLN LEU TYR ASN ARG TYR SEQRES 2 A 200 LYS ASP PRO GLN ASP GLU ASN LYS ILE GLY ILE ASP GLY SEQRES 3 A 200 ILE GLN GLN PHE CYS ASP ASP LEU ALA LEU ASP PRO ALA SEQRES 4 A 200 SER ILE SER VAL LEU ILE ILE ALA TRP LYS PHE ARG ALA SEQRES 5 A 200 ALA THR GLN CYS GLU PHE SER LYS GLN GLU PHE MET ASP SEQRES 6 A 200 GLY MET THR GLU LEU GLY CYS ASP SER ILE GLU LYS LEU SEQRES 7 A 200 LYS ALA GLN ILE PRO LYS MET GLU GLN GLU LEU LYS GLU SEQRES 8 A 200 PRO GLY ARG PHE LYS ASP PHE TYR GLN PHE THR PHE ASN SEQRES 9 A 200 PHE ALA LYS ASN PRO GLY GLN LYS GLY LEU ASP LEU GLU SEQRES 10 A 200 MET ALA ILE ALA TYR TRP ASN LEU VAL LEU ASN GLY ARG SEQRES 11 A 200 PHE LYS PHE LEU ASP LEU TRP ASN LYS PHE LEU LEU GLU SEQRES 12 A 200 HIS HIS LYS ARG SER ILE PRO LYS ASP THR TRP ASN LEU SEQRES 13 A 200 LEU LEU ASP PHE SER THR MET ILE ALA ASP ASP MET SER SEQRES 14 A 200 ASN TYR ASP GLU GLU GLY ALA TRP PRO VAL LEU ILE ASP SEQRES 15 A 200 ASP PHE VAL GLU PHE ALA ARG PRO GLN ILE ALA GLY THR SEQRES 16 A 200 LYS SER THR THR VAL SEQRES 1 C 77 GLY SER ASN ILE GLU GLU ASP ARG LYS LEU LEU ILE GLN SEQRES 2 C 77 ALA ALA ILE VAL ARG ILE MET LYS MET ARG LYS VAL LEU SEQRES 3 C 77 LYS HIS GLN GLN LEU LEU GLY GLU VAL LEU THR GLN LEU SEQRES 4 C 77 SER SER ARG PHE LYS PRO ARG VAL PRO VAL ILE LYS LYS SEQRES 5 C 77 CYS ILE ASP ILE LEU ILE GLU LYS GLU TYR LEU GLU ARG SEQRES 6 C 77 VAL ASP GLY GLU LYS ASP THR TYR SER TYR LEU ALA SEQRES 1 B 200 GLY SER ARG LYS LYS LEU GLU GLN LEU TYR ASN ARG TYR SEQRES 2 B 200 LYS ASP PRO GLN ASP GLU ASN LYS ILE GLY ILE ASP GLY SEQRES 3 B 200 ILE GLN GLN PHE CYS ASP ASP LEU ALA LEU ASP PRO ALA SEQRES 4 B 200 SER ILE SER VAL LEU ILE ILE ALA TRP LYS PHE ARG ALA SEQRES 5 B 200 ALA THR GLN CYS GLU PHE SER LYS GLN GLU PHE MET ASP SEQRES 6 B 200 GLY MET THR GLU LEU GLY CYS ASP SER ILE GLU LYS LEU SEQRES 7 B 200 LYS ALA GLN ILE PRO LYS MET GLU GLN GLU LEU LYS GLU SEQRES 8 B 200 PRO GLY ARG PHE LYS ASP PHE TYR GLN PHE THR PHE ASN SEQRES 9 B 200 PHE ALA LYS ASN PRO GLY GLN LYS GLY LEU ASP LEU GLU SEQRES 10 B 200 MET ALA ILE ALA TYR TRP ASN LEU VAL LEU ASN GLY ARG SEQRES 11 B 200 PHE LYS PHE LEU ASP LEU TRP ASN LYS PHE LEU LEU GLU SEQRES 12 B 200 HIS HIS LYS ARG SER ILE PRO LYS ASP THR TRP ASN LEU SEQRES 13 B 200 LEU LEU ASP PHE SER THR MET ILE ALA ASP ASP MET SER SEQRES 14 B 200 ASN TYR ASP GLU GLU GLY ALA TRP PRO VAL LEU ILE ASP SEQRES 15 B 200 ASP PHE VAL GLU PHE ALA ARG PRO GLN ILE ALA GLY THR SEQRES 16 B 200 LYS SER THR THR VAL SEQRES 1 D 77 GLY SER ASN ILE GLU GLU ASP ARG LYS LEU LEU ILE GLN SEQRES 2 D 77 ALA ALA ILE VAL ARG ILE MET LYS MET ARG LYS VAL LEU SEQRES 3 D 77 LYS HIS GLN GLN LEU LEU GLY GLU VAL LEU THR GLN LEU SEQRES 4 D 77 SER SER ARG PHE LYS PRO ARG VAL PRO VAL ILE LYS LYS SEQRES 5 D 77 CYS ILE ASP ILE LEU ILE GLU LYS GLU TYR LEU GLU ARG SEQRES 6 D 77 VAL ASP GLY GLU LYS ASP THR TYR SER TYR LEU ALA SEQRES 1 E 13 ACE MSE ILE LYS LEU MK8 SER LEU LYS MK8 GLN LYS LYS SEQRES 1 F 13 ACE MSE ILE LYS LEU MK8 SER LEU LYS MK8 GLN LYS LYS MODRES 3TDZ MSE E 1 MET SELENOMETHIONINE MODRES 3TDZ MK8 E 5 LEU 2-METHYL-L-NORLEUCINE MODRES 3TDZ MK8 E 9 LEU 2-METHYL-L-NORLEUCINE MODRES 3TDZ MSE F 1 MET SELENOMETHIONINE MODRES 3TDZ MK8 F 5 LEU 2-METHYL-L-NORLEUCINE MODRES 3TDZ MK8 F 9 LEU 2-METHYL-L-NORLEUCINE HET ACE E 0 3 HET MSE E 1 8 HET MK8 E 5 9 HET MK8 E 9 9 HET ACE F 0 3 HET MSE F 1 8 HET MK8 F 5 9 HET MK8 F 9 9 HETNAM ACE ACETYL GROUP HETNAM MSE SELENOMETHIONINE HETNAM MK8 2-METHYL-L-NORLEUCINE FORMUL 5 ACE 2(C2 H4 O) FORMUL 5 MSE 2(C5 H11 N O2 SE) FORMUL 5 MK8 4(C7 H15 N O2) FORMUL 7 HOH *485(H2 O) HELIX 1 1 SER A 61 TYR A 72 1 12 HELIX 2 2 GLY A 82 LEU A 93 1 12 HELIX 3 3 SER A 99 PHE A 109 1 11 HELIX 4 4 LYS A 119 GLY A 130 1 12 HELIX 5 5 SER A 133 LEU A 148 1 16 HELIX 6 6 GLU A 150 LYS A 166 1 17 HELIX 7 7 ASP A 174 LEU A 186 1 13 HELIX 8 8 PHE A 192 HIS A 204 1 13 HELIX 9 9 PRO A 209 ILE A 223 1 15 HELIX 10 10 PRO A 237 ARG A 248 1 12 HELIX 11 11 PRO A 249 ILE A 251 5 3 HELIX 12 12 ASN C 702 LYS C 723 1 22 HELIX 13 13 HIS C 727 SER C 739 1 13 HELIX 14 14 ARG C 745 LYS C 759 1 15 HELIX 15 15 ARG B 62 LYS B 73 1 12 HELIX 16 16 GLY B 82 LEU B 93 1 12 HELIX 17 17 SER B 99 PHE B 109 1 11 HELIX 18 18 LYS B 119 GLY B 130 1 12 HELIX 19 19 SER B 133 GLN B 140 1 8 HELIX 20 20 GLN B 140 LEU B 148 1 9 HELIX 21 21 GLU B 150 LYS B 166 1 17 HELIX 22 22 ASP B 174 LEU B 186 1 13 HELIX 23 23 PHE B 192 HIS B 204 1 13 HELIX 24 24 PRO B 209 ILE B 223 1 15 HELIX 25 25 PRO B 237 ARG B 248 1 12 HELIX 26 26 PRO B 249 ILE B 251 5 3 HELIX 27 27 ASN D 702 LYS D 723 1 22 HELIX 28 28 HIS D 727 SER D 739 1 13 HELIX 29 29 ARG D 745 LYS D 759 1 15 HELIX 30 30 LYS E 3 LYS E 11 1 9 HELIX 31 31 LYS F 3 LYS F 11 1 9 SHEET 1 A 3 LYS A 73 ASP A 74 0 SHEET 2 A 3 ASP A 77 ILE A 81 -1 O LYS A 80 N ASP A 74 SHEET 3 A 3 PHE A 117 SER A 118 -1 O PHE A 117 N ILE A 81 SHEET 1 B 3 VAL C 724 LYS C 726 0 SHEET 2 B 3 GLU C 768 TYR C 774 -1 O TYR C 772 N LEU C 725 SHEET 3 B 3 LEU C 762 VAL C 765 -1 N GLU C 763 O SER C 773 SHEET 1 C 2 LYS B 80 ILE B 81 0 SHEET 2 C 2 PHE B 117 SER B 118 -1 O PHE B 117 N ILE B 81 SHEET 1 D 3 VAL D 724 LYS D 726 0 SHEET 2 D 3 GLU D 768 TYR D 774 -1 O TYR D 772 N LEU D 725 SHEET 3 D 3 LEU D 762 VAL D 765 -1 N GLU D 763 O SER D 773 LINK OD1 ASP A 84 NZ LYS E 8 1555 1555 1.35 LINK C ACE E 0 N MSE E 1 1555 1555 1.33 LINK C MSE E 1 N ILE E 2 1555 1555 1.33 LINK C LEU E 4 N MK8 E 5 1555 1555 1.28 LINK C MK8 E 5 N SER E 6 1555 1555 1.28 LINK CE MK8 E 5 CE MK8 E 9 1555 1555 1.46 LINK C LYS E 8 N MK8 E 9 1555 1555 1.27 LINK C MK8 E 9 N GLN E 10 1555 1555 1.26 LINK C ACE F 0 N MSE F 1 1555 1555 1.33 LINK C MSE F 1 N ILE F 2 1555 1555 1.33 LINK C LEU F 4 N MK8 F 5 1555 1555 1.27 LINK C MK8 F 5 N SER F 6 1555 1555 1.27 LINK CE MK8 F 5 CE MK8 F 9 1555 1555 1.46 LINK C LYS F 8 N MK8 F 9 1555 1555 1.28 LINK C MK8 F 9 N GLN F 10 1555 1555 1.27 CRYST1 131.790 190.210 67.506 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007588 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005257 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014813 0.00000